Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Total Non-Current Liabilities (2016 - 2024)

Historic Total Non-Current Liabilities for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $29.0 billion.

  • Sanofi's Total Non-Current Liabilities rose 74.91% to $29.0 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $29.0 billion, marking a year-over-year increase of 74.91%. This contributed to the annual value of $27.5 billion for FY2024, which is 873.61% down from last year.
  • Sanofi's Total Non-Current Liabilities amounted to $29.0 billion in Q2 2025, which was up 74.91% from $27.5 billion recorded in Q4 2024.
  • Sanofi's Total Non-Current Liabilities' 5-year high stood at $35.9 billion during Q2 2021, with a 5-year trough of $27.5 billion in Q4 2024.
  • Its 5-year average for Total Non-Current Liabilities is $30.5 billion, with a median of $30.0 billion in 2023.
  • As far as peak fluctuations go, Sanofi's Total Non-Current Liabilities crashed by 1773.16% in 2022, and later surged by 663.58% in 2023.
  • Sanofi's Total Non-Current Liabilities (Quarter) stood at $34.2 billion in 2021, then decreased by 17.73% to $28.2 billion in 2022, then increased by 6.64% to $30.0 billion in 2023, then decreased by 8.25% to $27.5 billion in 2024, then grew by 5.28% to $29.0 billion in 2025.
  • Its Total Non-Current Liabilities was $29.0 billion in Q2 2025, compared to $27.5 billion in Q4 2024 and $28.8 billion in Q2 2024.